U.S. Markets close in 4 hrs 47 mins

Hemispherx Biopharma, Inc. (HEB)

NYSE MKT - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.475-0.005 (-1.104%)
As of 11:11AM EDT. Market open.
People also watch
  • KTOV = Mcap $16 Mil /Cash $17 Mil / ULTRA Low float / NDA submission for potential Blockbuster this Quarter = 20 BAGGER ..ONE OF THE BIGGEST BIOTECH OPPORTUNITY EVER ! Thank me later guys

    Kitov Pharma (KTOV)

    Market Cap: $17 M
    Cash $17 M
    Price: $1.50

    Shares Out: 10.6 Million

    Kitov Pharmaceuticals Initiates NDA Filing for KIT-302 as a Treatment for Osteoarthritis and Hypertension

    Kitov Expects to Submit an NDA for KIT-302 in the Third Quarter 2017.Kitov announced that it began the process of compiling the documents necessary to file an NDA for its lead asset KIT-302 as a treatment for patients who experience both osteoarthritis and hypertension. The Company hired Parexel International Corporation, a clinical research organization, to digitalize and formally submit its NDA application. Kitov expects the filing to occur during the third quarter of 2017, with a potential FDA approval during the second quarter of 2018.

    KIT-302 is a combination drug that treats osteoarthritis pain and hypertension simultaneously

    Primary efficacy endpoint achieved Lead drug candidate KIT-302 achieved its primary efficacy endpoint in a pivotal Phase III trial

    Marketing potential Pipeline candidates address large, multi-billion dollar markets


    Kitov’s current pipeline products, KIT-301 and KIT-302, are combination drugs that treat OA pain and HTN simultaneously. In December 2015, KIT-302 successfully achieved the primary efficacy endpoint for its Phase III clinical trial. In August 2016, the United States Patent Office issued a patent covering KIT-302.


    Of the 27 million Americans with OA, 50% also suffer from HTN, which is also a common side effect of stand-alone OA drugs. With no single medication currently treating both conditions, KIT-301 and KIT-302 are targeting this multi-billion dollar market.

  • It looks like The Scrupulous Thieves have found new investors to rob.
  • Same old pump and dump scenario as we saw hundreds of times in the past ...

    just more scam proof ...

    where are the cancer "trial" results from past decades ??????
  • More all time lows to expect in the coming weeks after the latest misleading PR ...

    same scenario as ever ...

    that's why Wall Street calls this fraud a scam ...
  • How to get back here if you are having trouble. https://finance.yahoo.com/quote/HEB/community?p=HEB

  • Monster Microcaps Alert to HEB shareholders. Clean Energy Technologies (CETY) opened their Europe Sales and Service Center for Europe sales and to serve 65 existing customers with CETY’s General Electric clean energy heat recovery systems and has already sold the first of hundreds of units to come.

    Each CETY Heat Recovery System sells for $300,000 and market demand is reported to several BILLION DOLLARS.

    CETY purchased Heat Recovery Systems in 2015 from General Electric and products are now very attractive to huge unmet markets and can achieve over $250 million annual sales within the next 2 years. Demand for conversion of wasted heat to electrical energy in big applications is VERY LARGE AND UNMET.

    Shares are steal with target of $.20 by year end and higher in 12 months.


    Clean Energy Technologies, Inc. Secures New Order for Waste Biomass Application in Europe
    COSTA MESA, Calif., July 12, 2017 /PRNewswire/ -- Clean Energy Technologies, Inc. (CETY) announced today that its subsidiary Heat Recovery Solutions has secured a new Clean CycleTM generator order for a Waste Biomass application in Europe. Growing d
  • Shorting the street gives one more energy than Redbull.
  • The end of a bashing fraud
  • Prepare to pay back every cent you stole bashers
  • The Silly Trap is up today...,
    I wonder why.... Heb will break them in the end
  • The day then frauds lose control will come
  • Good news and the criminal traders go wild...
  • Got a great report from http://jcharlesassets.com/opiant-pharmaceuticals/?s=HEB about $HEB. I did have to subscribe but it was worth the time. Thank you guys for the tip! "rht" Trading stocks investing.

    Best MicroCap, Small Cap and Emerging Stocks to Buy - J Charles Assets
    We search for the smart new growing companies to invest in with stock deals to watch in pharmacuetical and digital verticals.
  • Buying up as much as can now. It wil start going back up
  • lol!Shorties took it up the #$%$ bigtime today, it appears...m#$%$ive volume of about 1/4 of the entire float...in fact, the highest volume in the past 10 years...they seem so desperate to prevent HEB from raising funds at higher prices....and in doing so, keep shorting at extremely low levels,allowing institutions to buy m#$%$ive positions at ridiculously low prices....keep up the m#$%$ive shorting, and keep digging your own grave...lolSeems you`re being outplayed, shorty, BIGTIMEhow many shares are left for shorting...hmm?
  • Hebs time will come....

    IBX is working in close association with the MD Anderson Cancer Center with the goal of initiating human testing late next year. An other bashed company. The criminal bashing impire is the starting to crumble
  • Looks like the fraudgang and their tradingcomputors are done
    Heb will rule if there's any justice
  • pathetic thieves trading....
  • Try harder I want more as cheap as possible....
  • Admams shorty little luce stays even after the big day bailed the bashship